Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PepGen Inc. - Common Stock (NQ:PEPG)

1.310 -0.150 (-10.27%)
Streaming Delayed Price Updated: 1:26 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,262
Open 1.370
Bid (Size) 1.310 (2)
Ask (Size) 1.320 (11)
Prev. Close 1.460
Today's Range 1.310 - 1.380
52wk Range 1.160 - 19.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
From Pomerantz LLP
Via GlobeNewswire
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
From PepGen Inc.
Via Business Wire

Performance

YTD
-65.3%
-65.3%
1 Month
-53.4%
-53.4%
3 Month
-65.3%
-65.3%
6 Month
-85.5%
-85.5%
1 Year
-90.0%
-90.0%

More News

Read More
PepGen Announces Appointment of Two New Directors to its Board
From PepGen Inc.
Via Business Wire
What's Driving the Market Sentiment Around PepGen?
Via Benzinga
Why PepGen (PEPG) Stock Is Skyrocketing Today
Via Benzinga
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc - PEPG
From Pomerantz LLP
Via GlobeNewswire
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
From PepGen Inc.
Via Business Wire
PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls
Via Benzinga
PepGen to Participate in Upcoming Investor Conferences
From PepGen Inc.
Via Business Wire
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
From PepGen Inc.
Via Business Wire
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
Via Stocktwits
These stocks have an unusual volume in today's session
Via Chartmill
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
Via Stocktwits
These stocks are moving in today's after hours session
Via Chartmill
Which stocks are experiencing notable movement on Thursday?
Via Chartmill
Which stocks are moving on Thursday?
Via Chartmill
Top movers in Monday's session
Via Chartmill
These stocks are making the most noise in today's session.
Via Chartmill
These stocks are moving in today's session
Via Chartmill
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights
From PepGen Inc.
Via Business Wire
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
From PepGen Inc.
Via Business Wire
PepGen Announces CONNECT Program Updates
From PepGen Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is PepGen Inc. - Common Stock publicly traded?
Yes, PepGen Inc. - Common Stock is publicly traded.
What exchange does PepGen Inc. - Common Stock trade on?
PepGen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PepGen Inc. - Common Stock?
The ticker symbol for PepGen Inc. - Common Stock is PEPG on the Nasdaq Stock Market
What is the current price of PepGen Inc. - Common Stock?
The current price of PepGen Inc. - Common Stock is 1.310
When was PepGen Inc. - Common Stock last traded?
The last trade of PepGen Inc. - Common Stock was at 04/03/25 01:26 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.